Nerve disorder possible AZ side-effect: EU

·1-min read

Europe's medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barre syndrome, as a possible side-effect of AstraZeneca's COVID-19 vaccine, regular safety updates from the watchdog show.

The European Medicines Agency said a causal relationship between GBS and the AstraZeneca shot, known as Vaxzevria, was a "at least a reasonable possibility" after 833 cases of GBS were reported out of 592 million doses of the vaccine given worldwide by July 31.

The EMA categorised the side-effect as "very rare," the lowest frequency of side-effect category it has, and has emphasised that the benefits of the shot outweigh the risks.

The US Food and Drug Administration has added a warning over Guillain-Barre syndrome as a possible side-effect of Johnson & Johnson's shot.

Both vaccines use viral vector technology and have also been associated with rare blood clots.

The EMA also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca's shot.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting